Corrigendum to 'Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice' Mol Metabol 29 (November 2019) 145-157.

Mol Metab

Department of Medicine, University of Louisville, Louisville, KY 40202, USA; Department of Pharmacology & Toxicology, University of Louisville, Louisville, KY 40202, USA; Hepatobiology & Toxicology Center, University of Louisville, Louisville, KY 40202, USA; Alcohol Research Center, University of Louisville, Louisville, KY 40202, USA. Electronic address:

Published: May 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191246	PMC
http://dx.doi.org/10.1016/j.molmet.2020.100999	DOI Listing

Publication Analysis

corrigendum 'fibroblast

'fibroblast growth

growth factor

factor required

required therapeutic

therapeutic effects

effects lactobacillus

lactobacillus rhamnosus

rhamnosus fructose-induced

fructose-induced fatty

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!